NivolumabGrade 1 interstitial pneumonia and neurologic toxicity: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1908卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16165-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：437 / 437

相关论文

共 50 条

[1] MethotrexateAcute interstitial pneumonia due to drug toxicity : case report
[J]. Reactions Weekly, 2020, 1832 (1) : 193 - 193
[2] AntibacterialsGastrointestinal toxicity and neurologic toxicity: case report
[J]. Reactions Weekly, 2019, 1775 (1) : 57 - 57
[3] AntineoplasticsAcquired drug resistance, bone marrow toxicity and interstitial pneumonia: case report
[J]. Reactions Weekly, 2022, 1935 (1) : 54 - 54
[4] PranlukastFirst report of interstitial pneumonia: case report
[J]. Reactions Weekly, 2001, 876 (1) : 10 - 10
[5] EndostatinFirst report of interstitial pneumonia: case report
[J]. Reactions Weekly, 2010, 1328 (1) : 18 - 18
[6] RegorafenibFirst report of interstitial pneumonia: case report
[J]. Reactions Weekly, 2015, 1578 (1) : 252 - 252
[7] AlemtuzumabFirst report of interstitial pneumonia: case report
[J]. Reactions Weekly, 2008, 1188 (1) : 5 - 5
[8] AnagrelideFirst report of interstitial pneumonia: case report
[J]. Reactions Weekly, 2003, 977 (1) : 6 - 6
[9] NivolumabGrade 5 colitis: case report
[J]. Reactions Weekly, 2020, 1822 (1) : 232 - 232
[10] Denosumab/nivolumabGrade 2 immune-related rheumatological toxicity and hypopituitarism: case report
[J]. Reactions Weekly, 2022, 1891 (1) : 118 - 118

← 1 2 3 4 5 →